Author:
Chen Fangfang,Tang Houlin,Han Juan,Li Dongmin,Li Peilong,Wang Ning,Han Mengjie,Wang Lan,Wang Lu
Abstract
BackgroundsLittle was known about the impact of HCV prior infection on HIV transmission and acquisition. We aimed to explore whether HCV prior infection and its interactions with unprotected sex affected HIV acquisition.MethodsThis study was conducted among HIV heterosexual serodiscordant couples whose index cases were receiving treatment during 2008–2014 in Zhumadian. At baseline, we collected information on demographics and medical history of ART use, CD4 count, and HIV viral load for index partners, and also HIV and HCV status for non-index partners. For each year's visit, we followed up on sexual behaviors among couples in the recent year and HIV seroconversion of non-index partners. Analyses of the Cox model and synergistic interaction were performed.ResultsWe identified 81 HIV seroconversions over 18,370.39 person-years, with the overall HIV seroconversion rate of 0.44 per 100 person-years. Couples, whose index cases were aged 50 years and above, had a baseline viral load >400 copies per ml and no AIDS-defining illness, and newly-initiated ART in the study period had a higher risk of HIV seroconversion. Unprotected sex and HCV prior infection showed a synergistic association with HIV acquisition risk (RERI = 3.65, SI = 0.48, AP = 2.24).ConclusionUnprotected sex and HCV infection were independent risk factors associated with HIV acquisition. The coexistence of them might have a synergistic effect on the risk which needs further research.
Reference33 articles.
1. Global progress report on HIV, viral hepatitis and sexually transmitted infections2021
2. Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment;Shahriar;Front Microbiol.,2022
3. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis;Platt;Lancet Infect Dis.,2016
4. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study;Trickey;Lancet Gastroenterol Hepatol.,2019
5. A tale of two viruses: immunological insights into HCV/HIV coinfection;Gobran;Front Immunol.,2021